France · Source-listed medicine information

France / CIS 68635586

NERVOPAX, comprimé orodispersible

comprimé orodispersible · sublinguale

Directory source checks passedOriginal source language: French

Source data retrieved: 2026-09-17. Clinical review is not yet available.

Formcomprimé orodispersible
Routesublinguale
Ingredient entries8
CountryFrance

Product identity

At a glance

Authorisation holder
LEHNING
Authorisation status
Autorisation active
Market status
Commercialisée
Country
France
Source reference
CIS 68635586

Reported market status does not confirm current pharmacy stock.

From the official composition record

Ingredients & strength

Source entries are shown individually. An active substance (SA) and its reference moiety (FT) may describe the same ingredient; do not add their strengths together.

Source composition entries for NERVOPAX, comprimé orodispersible
IngredientStrength / referenceSource role
CUPRUM ACETICUM POUR PRÉPARATIONS HOMÉOPATHIQUEScomprimé(30 mg) 4 DHun compriméSAGroup 1
MAGNESIA PHOSPHORICA POUR PRÉPARATIONS HOMÉOPATHIQUEScomprimé(30 mg) 3 DHun compriméSAGroup 3
SILICEA POUR PRÉPARATIONS HOMÉOPATHIQUEScomprimé(30 mg) 5 DHun compriméSAGroup 4
ATROPINUM SULFURICUM POUR PRÉPARATIONS HOMÉOPATHIQUEScomprimé(30 mg) 6 DHun compriméSAGroup 5
ARSENICUM ALBUM POUR PRÉPARATIONS HOMÉOPATHIQUEScomprimé(30 mg) 6 DHun compriméSAGroup 6
ZINCUM VALERIANICUM POUR PRÉPARATIONS HOMÉOPATHIQUEScomprimé(30 mg) 4 DHun compriméSAGroup 7
CORALLIUM RUBRUM POUR PRÉPARATIONS HOMÉOPATHIQUEScomprimé(30 mg) 7 DHun compriméSAGroup 9
AGNUS CASTUS POUR PRÉPARATIONS HOMÉOPATHIQUEScomprimé(30 mg) 3 DHun compriméSAGroup 10

Pack references

Presentations (1)

4 plaquette(s) thermoformée(s) PVC PVDC aluminium de 20 comprimé(s)

CIP13 3400930206096

Présentation active · Déclaration de commercialisation

From the French medicines authority

Official documents

The official product entry provides access to the patient leaflet and professional product information when available. Documents are in French and availability varies by medicine.

Open the official product entryBDPM · CIS 68635586 · Opens in a new tab

Check the medicine name, strength and form against your pack. The authority’s current documents may be newer than the catalogue snapshot shown here.

Where this information comes from

Sources & dates

Base de données publique des médicaments (BDPM), France. Retrieval dates record when we obtained the source files; they are not clinical review dates or a guarantee of current stock.

Source files and their retrieval dates
Source fileRetrievedSource file modified
fr_products.txtNot supplied
fr_composition.txtNot supplied
fr_packs.txtNot supplied

Directory source checks cover the factual catalogue record.Molindra clinical guidance has not yet been reviewed or published for this medicine.

Our sources and review process →